Evaxion Biotech A/S - American Depositary Share (EVAX)
2.9900
-0.2800 (-8.56%)
Evaxion Biotech A/S is a biotechnology company that focuses on the development of innovative immunotherapies and personalized cancer treatments using its proprietary artificial intelligence platform
The company specializes in designing and developing therapeutic vaccines that harness the body's immune system to target and destroy cancer cells. By leveraging advanced machine learning algorithms, Evaxion aims to identify optimal vaccine candidates tailored to individual patients, with the goal of providing more effective and customized treatment options for various types of cancer and infectious diseases.
Frequently Asked Questions
Is Evaxion Biotech A/S - American Depositary Share publicly traded?
Yes, Evaxion Biotech A/S - American Depositary Share is publicly traded.
What exchange does Evaxion Biotech A/S - American Depositary Share trade on?
Evaxion Biotech A/S - American Depositary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Evaxion Biotech A/S - American Depositary Share?
The ticker symbol for Evaxion Biotech A/S - American Depositary Share is EVAX on the Nasdaq Stock Market
What is the current price of Evaxion Biotech A/S - American Depositary Share?
The current price of Evaxion Biotech A/S - American Depositary Share is 2.990
When was Evaxion Biotech A/S - American Depositary Share last traded?
The last trade of Evaxion Biotech A/S - American Depositary Share was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Evaxion Biotech A/S - American Depositary Share?
The market capitalization of Evaxion Biotech A/S - American Depositary Share is 113.31M
How many shares of Evaxion Biotech A/S - American Depositary Share are outstanding?
Evaxion Biotech A/S - American Depositary Share has 37.90M shares outstanding.